|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 优质红葡萄酒酿造中浸提多酚物质最有效的工具——新一代果胶酶EX-V的应用显示文摘经过在法国赤霞珠葡萄酒上2年多的精心研究,一种新型浸提多酚果胶酶Lallzyme EX-V终于被开发成功。大量的试验和使用结果表明:该果胶酶EX-V在对新鲜红葡萄酒和陈酿1年的红葡萄酒的颜色和单宁结构上具有显著的提升作用;此外,对香气和多酚类物质的分析显示,该果胶酶在促进聚合多酚和品种香气上具有明显的效果;品评结果也显示,经过该果胶酶处理的葡萄酒表现亦最佳,特别是香气、风味和综合复杂性。 | Dr.David Guerrand Jean-Philippe Gervais 郭永亮 李新榜 | 2003 | 中外葡萄与葡萄酒2003，，2： | 13 |
| 2 | 单侧小肾细胞癌射频消融术与保肾手术的效价比分析显示文摘目的评价经皮射频消融术(RF)与保留肾单位手术(NSS)治疗小的(直径≤4cm)肾细胞癌的相对成本效益,制定出社会希望支付,普遍可接受的费用水平。方法建立马尔可夫(Markov)决策分析模型,评估接受射频消融或保肾手术的65岁组小肾细胞癌病人的预期寿命及相关花费。模型的建立考虑到了肾癌的状况、治疗效果、费用及近期和远期疗效等综合因素。在假定每个质量校正生存年(QALY)费用为75000美元的前提下,分析判定优选治疗方案如何能提高性价比。在预期范围内引导完善的新式医疗保健干预措施。用敏感性来反映主要参数的变化结果。结果通过运用案例假设,NSS后有质量的生活时间略长于RF(2.5d), | P.V. Pandharipande D.A. Gervais P.R. Mueller C. Hur G.S. Gazelle. 邢艳(译) 刘文亚(校) 唐光健(校) | 2008 | 国际医学放射学杂志2008，31，5： | 7 |
| 3 | Synthesis of Single-Walled Carbon Nanotubes by Induction Thermal Plasma显示文摘The production of high quality single-walled carbon nanotubes(SWCNTs)on a bulk scale has been an issue of considerable interest.Recently,it has been demonstrated that high quality SWCNTs can be continuously synthesized on large scale by using induction thermal plasma technology.In this process,the high energy density of the thermal plasma is employed to generate dense vapor-phase precursors for the synthesis of SWCNTs.With the current reactor system,a carbon soot product which contains approximately 40 wt%of SWCNTs can be continuously synthesized at the high production rate of~100 g/h.In this article,our recent research efforts to achieve major advances in this technology are presented.Firstly,the processing parameters involved are examined systematically in order to evaluate their individual inuences on the SWCNT synthesis.Based on these results,the appropriate operating conditions of the induction thermal plasma process for an effective synthesis of SWCNTs are discussed.A characterization study has also been performed on the SWCNTs produced under the optimum processing conditions.Finally,a mathematical model of the process currently under development is described.The model will help us to better understand the synthesis of SWCNTs in the induction plasma process. | Keun Su Kim Ala Moradian Javad Mostaghimi Yasaman Alinejad Ali Shahverdi Benoit Simard Gervais Soucy | 2009 | Nano Research2009，2，10： | 4 |
| 4 | The development of a family of zinc-based foundry alloys显示文摘 | GERVAIS E LEVERT H BESS M | 1980 | Transactions of the American Foundrymen''s Society1980，88，： | 1 |
| 5 | Synergistic and antagonistic effects of combined subzero temperature and high pressure on inactivation of Escherichia coli显示文摘 | MOUSSA M PERRIER-CORNET J M GERVAIS P | 2006 | Appl Environ Microbiol2006，72，1： | 1 |
| 6 | Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer(EURTAC):a multicentre,open-label,randomised phase 3 trial显示文摘 | Rosell R Carcereny E Gervais R | 2012 | Lancet Oncol2012，13，3： | 1 |
| 7 | Assessing indicators of agricultural drought impacts on spring wheat yield and quality on the Canadian prairies显示文摘 | Mkhabela M Bullock P Gervais M | 2010 | Agricultural and Forest Meteorology2010，150，3： | 1 |
| 8 | Pulsed laser deposition of fferroelectric BST thin films on perovskite substrates:an Infrared Characterization显示文摘 | Gervais M Gervais F | 2001 | The International Journal of Inorganic Materials2001，3，7： | 1 |
| 9 | Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: An intergroup study FNCLCC cleo0d-IFCT 00-01 显示文摘 | Pujol JL Breton JL Gervais R | 2007 | J Clin Oncol2007，25，25： | 1 |
| 10 | Phase Ⅱ randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)显示文摘 | Gervais R Ducolone A Breton J L | 2005 | Ann Oncol2005，16，1： | 1 |
| 11 | Learning to Be Overconfident显示文摘 | Gervais S Odean T | 2001 | The Review of Financial Studies2001，14，1： | 1 |
| 12 | The meas- urement of cable tension by the vibratory method显示文摘 | ROBERT J L BRUHAT D GERVAIS J P | 1991 | Bulletin De Liaison Des Laboratoires Des Ponts Et Chaussees France1991，173，7： | 1 |
| 13 | Effect of grain and forage fractions of corn silage on milk production and composition in dairy cows 显示文摘 | Boivin M Gervais R Chouinard PY | 2013 | Animal2013，7，2： | 1 |
| 14 | Constrained multivariable control of a distillation column using a simplified model predictive control algorithm显示文摘 | Abou-Jeyab R A Gupta Y P Gervais J R | | 0，，05： | 1 |
| 15 | MRI signal distribution within the intcrvertcbral disc as a biomarker of adolescent idiopathic scoliosis and spondylolisthesis显示文摘 | Gervais J Pcrie D Parent S | 2012 | BMC Musculoskelet Disord2012，13，： | 1 |
| 16 | Erlotinib versuschemotherapy (CT) in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemo-therapy (EURTAC) phase III randomized trial 显示文摘 | Rosell R Gervais R Vergnenegre A | 2011 | J Clin Oncol2011，29，15： | 1 |
| 17 | Erlotinib versus standard chemotherapy as first-line treatment for European patients with advaneed EGFR mutation-positive non-small-cell lung cancer (EURTAC) : a multicentre, open-label, randomised phase 3 trial 显示文摘 | Rosell R Carcereny E Gervais R | 2012 | Lancet Oncnl2012，13，3： | 1 |
| 18 | Mise à jour sur les considérations pharmacocinétiques, pharmacodynamiques et les interactions médicamenteuses dans le choix d’une benzodiazépine显示文摘 | P. Landry M. Gervais K.P. O’Connor | 2008 | Annales médico-psychologiques2008，，7： | 1 |
| 19 | Surface electrocardio- gram to predict outcome in candidates for cardiac resynchroniza- tion therapy: a sub-analysis of the CARE-HF trial显示文摘 | Gervais R Leclercq C Shankar A | 2009 | Eur J Heart Fail2009，11，： | 1 |
| 20 | Ex vivo expansion of antitumor cytotoxic lymphocytes with tumor-associated antigen-loaded dendritic cells显示文摘 | Gervais A Bouet-Toussaint F Toutirais O | 2005 | Anticancer Res2005，25，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员